Top broker says Sonic (ASX:SHL) share price is a buy

Here's what this broker thinks of the Sonic share price…

| More on:
Lab worker puts hands in the air and dances around

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sonic Healthcare Limited (ASX: SHL) share price was out of form on Tuesday.

The healthcare company's shares were caught up in the selloff and sank 4% to $39.46.

Is the Sonic share price weakness a buying opportunity?

One leading broker that is likely to see the weakness in the Sonic share price as a buying opportunity is Morgans.

According to a recent note, the broker has an add rating and $45.98 price target on its shares.

Based on the current Sonic share price, this implies potential upside of 16.5% over the next 12 months before dividends.

In addition, Morgans is forecasting a 95 cents per share dividend in FY 2022. If you include this, the total potential return stretches to 19%.

What did the broker say?

Morgans likes Sonic for a number of reasons. One of those is its belief that the company will continue to benefit from COVID testing. While it acknowledges that peak testing may be behind us, it feels the outlook for testing remains strong.

Another reason the broker is bullish on the Sonic share price is its balance sheet. It believes the company has $1.5 billion of balance sheet capacity to use on acquisitions to support its growth.

Morgans commented: "We see COVID-19 testing continuing into the foreseeable future, with growth potential in COVID serology testing. SHL's global base business is increasingly resilient, benefitting from geographical diversity. Strong B/S (gearing 21.6x; A$1.3bn headroom) opening the door to acquisitions, contracts and JVs."

So, although the Sonic share price is smashing the market in 2021 with a 20% gain, Morgans doesn't believe it is too late for investors to get on board. This could make it worth considering, especially after market volatility this week dragged its shares lower.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

children and teacher in childcare education setting
Broker Notes

Why did Macquarie just re-rate G8 Education shares?

G8 Education shares are down 23% this year.

Read more »

A man looking at his laptop and thinking.
Broker Notes

After crashing more than 21% yesterday, does Macquarie rate Helia shares a buy?

Should I buy the big dip on Helia shares? Here’s Macquarie’s latest share price forecast.

Read more »

Happy work colleagues give each other a fist pump.
Broker Notes

Buy this ASX 200 share that is having a 'milestone year'

Bell Potter has good things to say about this high-flying stock.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in July

The broker is feeling bullish on these names this month. Let's find out why.

Read more »

Woman and man calculating a dividend yield.
Financial Shares

With a 3.8% dividend yield, does Macquarie rate QBE shares a buy, hold or sell?

Can QBE shares continue to outperform in FY 2026? Here’s Macquarie’s latest forecast.

Read more »

watch
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Up 50% in a year, does Macquarie forecast further upside for Computershare shares?

Let's see what the broker is saying about this high-flying blue chip.

Read more »

Two brokers analysing stocks.
Broker Notes

What does JP Morgan think Aussie Broadband shares are worth?

Aussie Broadband shares are up more than 100% in five years.

Read more »